Abstract:Enteroendocrine L cells and glucagon-like peptide 2 (GLP-2) secretion are activated in the intestinal adaptation process following bowel resection in patients with short bowel syndrome. We hypothesized that enteral activation of Takeda G protein-coupled receptor 5 (TGR5), expressed in enteroendocrine L cells, could augment endogenous GLP-2 secretion and the intestinal adaptation response. Our aim was to assess the efficacy of different TGR5 agonists to stimulate GLP-2 secretion and intestinal adaptation in a piglet short-bowel model. In study 1, parenterally fed neonatal pigs (n = 6/group) were gavaged with vehicle, olive extract (OE: 10 or 50 mg/kg), or ursolic acid (UA; 10 mg/kg), and plasma GLP-2 was measured for 6 h. In study 2, neonatal pigs (n = 6-8/group) were subjected to transection or 80% mid-small intestine resection and, after 2 days, assigned to treatments for 10 days as follows: I) transection + vehicle (sham), 2) resection + vehicle (SBS), 3) resection + 30 mg UA (SBS + UA), and 4) resection + 180 mg/kg OE (SBS + OE.). We measured plasma GLP-2, intestinal histology, cell proliferation, and gene expression, as well as whole body citrulline-arginine kinetics and bile acid profiles. In study 1, GLP-2 secretion was increased by UA and tended to be increased by OE. In study 2, SBS alone, but not additional treatment with either TGR5 agonist, resulted in increased mucosal thickness and crypt cell proliferation in remnant jejunum and ileum sections. SBS increased biliary and ileal concentration of bile acids and expression of inflammatory and farnesoid X receptor target genes, but these measures were suppressed by UA treatment. In conclusion. UA is an effective oral GLP-2 secretagogue in parenterally fed pigs but is not capable of augmenting GLP-2 secretion or the intestinal adaptation response after massive small bowel resection.NEW & NOTEWORTHY Therapeutic activation of endogenous glucagon-like peptide 2 (GLP-2) secretion is a promising strategy to improve intestinal adaptation in patients with short bowel syndrome. This study in neonatal pigs showed that oral supplementation with a selective Takeda G protein-coupled receptor 5 (TGR5) agonist is an effective approach to increase GLP-2 secretion. The results warrant further study to establish a more potent oral TGR5 agonist that can effectively improve intestinal adaptation in pediatric patients with SBS.

Peptide YY induces intestinal proliferation in peptide YY knockout mice with total enteral nutrition after massive small bowel resection.

Peptide YY induces enterocyte proliferation in a rat model with total enteral nutrition after distal bowel resection

The adaptive effects of residual intestine of peptide YY in mice with total enteral nutrition after massive small bowel resection

The cellular signal transduction pathway of peptide YY on residual intestinal epithelial cells in a model of PYY knockout mice after massive small bowel resection

Effects of Glucagon-Like Peptide 2 on the Adaptation of Residual Small Bowel in a Rat Model of Short Bowel Syndrome

Alteration of glucagon-like peptide-2 (GLP-2) on proliferation of intestinal mucosa in rats following small bowel resection and its time-dependent pattern

Nutritional supplementation with transforming growth factor-beta inhibits intestinal adaptation after massive small bowel resection in a rat

Peptide YY(1-36) and Peptide YY(3-36): Part II. Changes after Gastrointestinal Surgery and Bariatric Surgery: Part I. Distribution, Release and Actions appeared in the last issue (May 2006)

Mechanisms of peptide YY release induced by an intraduodenal meal in rats: neural regulation by proximal gut

Differential Action Of Tgr5 Agonists On Glp-2 Secretion And Promotion Of Intestinal Adaptation In A Piglet Short Bowel Model

Effects of Recombinant Human Growth Hormone on the Adaptation of the Remnant Small Intestine in Short Bowel Rats

The effect of Peptide YY on bacterial translocation in rat with acute pancreatitis

Bile salt dependent lipase promotes intestinal adaptation in rats with massive small bowel resection.

Effects of enteral nutrition with low carbohydrate,high fat and high protein on a mice model after massive small bowel resection

The vagus nerve mediates the physiological but not pharmacological effects of PYY3-36 on food intake

Effects of Continuous Enteral L-arginine in a Rat Model of the Short Bowel Syndrome.

Effects of GLP-2 on Mouse Intestinal Mucosal Proliferation after Ischemia/reperfusion Insult

Short-peptide-based enteral nutrition affects rats MDP translocation and protects against gut-lung injury via the PepT1-NOD2-beclin-1 pathway in vivo

PSXI-33 Differential Action of TGR5 Agonists on GLP-2

Pyrroloquinoline Quinone Regulates Enteric Neurochemical Plasticity of Weaned Rats Challenged with Lipopolysaccharide.

An Experimental Study on the Effect of GLP-2 on the Function of Remnant Ileum in Rats with Short Bowel Syndrome